Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1CNS 1

Conditions

Head and Neck Neoplasms 174Squamous Cell Carcinoma of Head and Neck 147Nasopharyngeal Carcinoma 126Oropharyngeal Neoplasms 25Thyroid Neoplasms 23Nasopharyngeal Neoplasms 21Mouth Neoplasms 21Carcinoma, Squamous Cell 19Laryngeal Neoplasms 17Neoplasms 15Radiation Injuries 13Hypopharyngeal Neoplasms 13Salivary Gland Neoplasms 11Carcinoma 11Stomatitis 10Recurrence 10Laryngeal Diseases 10Tongue Neoplasms 9Mucositis 8Parkinson Disease 4, Autosomal Dominant Lewy Body 7Pain 7Neoplasm Metastasis 7Esthesioneuroblastoma, Olfactory 7Xerostomia 6Uterine Cervical Neoplasms 6Differentiated Thyroid Cancer 6Breast Neoplasms 6Thyroid Cancer, Papillary 5Parathyroid Neoplasms 4Melanoma 4

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Ototoxicity × Head & Neck × Clear all
NCT01216800 2010-10-07

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
84 enrolled
Head & Neck

Ototoxicity, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡